Editorial: New drugs in lipid lowering therapy - Report - MDSpire

Editorial: New drugs in lipid lowering therapy

  • By

  • Ibadete Bytyçi

  • Maciej Banach

  • Ivan Pećin

  • May 28, 2026

  • 0 min

Share

Clinical Report: Emerging Pharmacological Options in Lipid-Lowering Treatment

Overview

{'add': 'Provide specific examples of cost and long-term safety concerns.'}

Background

{'add': 'Include statistics on statin intolerance prevalence.'}

Data Highlights

{'add': 'Incorporate qualitative data or references to support claims.'}

Key Findings

{'add': 'Include specific numerical outcomes from referenced studies.'}

Clinical Implications

{'expand': 'Detail monitoring strategies for adverse effects and cost considerations.'}

Conclusion

{'expand': 'Mention ongoing research trials or studies.'}

Related Resources & Content

  1. Mercep et al., European Journal of Preventive Cardiology, 2023 -- Emerging Pharmacological Options in Lipid-Lowering Treatment
  2. Rogozik et al., European Journal of Preventive Cardiology, 2023 -- Case Report on Inclisiran
  3. Hu et al., European Journal of Preventive Cardiology, 2023 -- Network Meta-Analysis on Lp(a)-Targeted Therapies
  4. Marcinkowska et al., European Journal of Preventive Cardiology, 2023 -- Machine Learning and Lipid Biomarkers
  5. The Journal of Clinical Endocrinology & Metabolism — Response to the Editorial by Fu et al: "Insights from Machine Learning on the Role of Lipoproteins in Liver Triglyceride Levels and Inflammatory Processes
  6. European Journal of Preventive Cardiology — Lipid management after an acute coronary syndrome: reasons to hope, reasons to persist
  7. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
  8. Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
  9. Some Improvement in Post-ACS Outcomes with Adjunctive Ezetimibe | NEJM Clinician

Original Source(s)

Editorial: New drugs in lipid lowering therapy

  • by Ibadete Bytyçi, Maciej Banach, Ivan Pećin

  • May 28, 2026

Related Content

Correlation between cardiorespiratory fitness and body composition in individuals with different glucose metabolism statuses

Case Report: Selective metal cell excision during open TAVR implantation preserves coronary access while maintaining valve integrity and function

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial